LifeSpan ePTFE Vascular Grafts for peripheral vascular reconstructions and AV Access have been used in clinical practice for more than 15 years. It features soft ePTFE material with superb suture ...

The FlowLine Bipore ePTFE vascular graft has unique Bipore design with two different fibril lengths for low thrombogenicity. An additional ePTFE wrap guarantees enhanced suture retention and high ...

Allogenic MHC-wild-type artery grafts maintain 100% patency in a rhesus model. Credit: Cell Reports Medicine (2025). DOI: 10.1016/j.xcrm.2025.102002 ...

Using this model, the authors experimented with different graft compositions—naked ePTFE grafts, grafts lined with AECs ...

Scientists at the Wisconsin National Primate Research Center and the Morgridge Institute for Research at the University of Wisconsin–Madison developed a universal, small diameter, vascular graft ...

By the 1970s, commercial vascular grafts were introduced, made primarily from Dacron fabric or expanded Teflon (ePTFE). These larger diameter (>5mm) grafts work satisfactorily for replacing or ...

--Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, announced the publication of a preclinical ...

Global Man made Vascular Graft Market Size was estimated at USD 3430.67 million in 2021 and is projected to reach USD 5042.41 million by 2028, exhibiting a CAGR of 5.66% during the forecast period.

[3,4,5] For vascular access in hemodialysis patients, ePTFE arteriovenous grafts are associated with complication rates that are close to three times higher than rates with vein fistulae.